louisiana semaglutide class action gastrointestinal obstruction Ozempic Lawsuit for Gastroparesis Ozempic Lawsuit [July 2026 Update]

Pushing the Boundaries of GLP-1 Innovation Hanmi to Present Six Obesity Drug Studies at ADA 2025Hanmi Pharmaceutical to Unveil Six Research Updates on HM15275 and HM17321 at ADA 2025Phase 1 Results of Next-Generation Triple Agonist HM15275 to Be Unveiled for the First Time

An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications that do not appear on drug labels.

Research on the connection between type 2 diabetes and liver disease is relatively recent, according to the Centers for Disease Control and Prevention

Heres what you need to know about the direct implications...